{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:57:18Z","timestamp":1775645838721,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011190","name":"Kunming Institute of Botany, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073725"],"award-info":[{"award-number":["82073725"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773737"],"award-info":[{"award-number":["81773737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060656"],"award-info":[{"award-number":["82060656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.thromres.2024.109041","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:25:27Z","timestamp":1716485127000},"page":"109041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Structure and pharmacokinetics\/pharmacodynamics of the anticoagulant tetradecasaccharide oHG-14 as an intrinsic tenase inhibitor"],"prefix":"10.1016","volume":"240","author":[{"given":"Taocui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanni","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.thromres.2024.109041_bb0005","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/17425255.2018.1530213","article-title":"Pharmacokinetics of new oral anticoagulants: implications for use in routine care","volume":"14","author":"Ingrasciotta","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"8","key":"10.1016\/j.thromres.2024.109041_bb0010","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.3390\/ijms24086879","article-title":"Challenges of anticoagulant therapy in atrial fibrillation\u2014focus on gastrointestinal bleeding","volume":"24","author":"Scridon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.thromres.2024.109041_bb0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/qjmed\/hcz171","article-title":"Direct oral anticoagulants in cirrhosis\u2014safe and effective alternative to traditional anticoagulants","volume":"112","author":"Donnelly","year":"2019","journal-title":"QJM-Int J Med"},{"key":"10.1016\/j.thromres.2024.109041_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.thromres.2021.03.026","article-title":"Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism","volume":"202","author":"Douros","year":"2021","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2024.109041_bb0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1084\/jem.20060217","article-title":"Are hemostasis and thrombosis two sides of the same coin?","volume":"203","author":"Colman","year":"2006","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.thromres.2024.109041_bb0030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.hoc.2016.05.007","article-title":"The intrinsic pathway of coagulation as a target for antithrombotic therapy","volume":"30","author":"Wheeler","year":"2016","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"5","key":"10.1016\/j.thromres.2024.109041_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.thromres.2024.109041_bb0040","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.drudis.2014.06.028","article-title":"Factor IXa as a target for anticoagulation in thrombotic disorders and conditions","volume":"19","author":"Smiley","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.thromres.2024.109041_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100615","article-title":"From multi-target anticoagulants to DOACs, and intrinsic coagulation factor inhibitors","volume":"39","author":"Lin","year":"2020","journal-title":"Blood Rev."},{"issue":"4","key":"10.1016\/j.thromres.2024.109041_bb0050","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.ATV.0000259363.91070.f1","article-title":"Factor IXa inhibitors as novel anticoagulants","volume":"27","author":"Howard","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2024.109041_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1538-7836.2007.02872.x","article-title":"Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study","volume":"6","author":"B.I. Eriksson, O.E. Dahl, M.R. Lassen, D.P. Ward, R. Rothlein, G. Davis, A.G. Turpie, G. Fixit Study","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"10016","key":"10.1016\/j.thromres.2024.109041_bb0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(15)00515-2","article-title":"Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial","volume":"387","author":"Lincoff","year":"2016","journal-title":"Lancet"},{"issue":"10016","key":"10.1016\/j.thromres.2024.109041_bb0065","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(15)00727-8","article-title":"An anticoagulant too good to be true for revascularisation","volume":"387","author":"Verheugt","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.thromres.2024.109041_bb0070","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/med.21503","article-title":"Recent advances in the discovery and development of factor XI\/XIa inhibitors","volume":"38","author":"Al-Horani","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.thromres.2024.109041_bb0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/jth.15126","article-title":"New anticoagulants: moving beyond the direct oral anticoagulants","volume":"19","author":"Fredenburgh","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109041_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112796","article-title":"The components and activities analysis of a novel anticoagulant candidate dHG-5","volume":"207","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.thromres.2024.109041_bb0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0040-1708480","article-title":"Effects of native fucosylated glycosaminoglycan, its depolymerized derivatives on intrinsic factor Xase, coagulation, thrombosis, and hemorrhagic risk","volume":"120","author":"Zhou","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2024.109041_bb0090","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/00019501-199211000-00002","article-title":"Heparin and low-molecular-weight heparins","volume":"3","author":"Hirsh","year":"1992","journal-title":"Coronary Artery Dis"},{"issue":"5","key":"10.1016\/j.thromres.2024.109041_bb0095","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-2007-982080","article-title":"Variability of heparins and heterogeneity of low molecular weight heparins","volume":"33","author":"Bianchini","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.109041_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/glycob\/cwac068","article-title":"Investigation of the pharmacokinetic properties of synthetic heparan sulfate oligosaccharides","volume":"33","author":"Arnold","year":"2023","journal-title":"Glycobiology"},{"issue":"12","key":"10.1016\/j.thromres.2024.109041_bb0105","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00003088-200342120-00003","article-title":"Pharmacodynamic and pharmacokinetic properties of enoxaparin","volume":"42","author":"Fareed","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.thromres.2024.109041_bb0110","first-page":"252","article-title":"Population pharmacokinetics of fondaparinux administered at prophylactic doses after major orthopaedic surgery in everyday practice","volume":"104","author":"Delavenne","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109041_bb0115","first-page":"2941","article-title":"Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study","volume":"6","author":"Ramadan","year":"2011","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.thromres.2024.109041_bb0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/md19040212","article-title":"Pharmacokinetics and pharmacodynamics of a depolymerized glycosaminoglycan from Holothuria fuscopunctata, a novel anticoagulant candidate, in rats by bioanalytical methods","volume":"19","author":"Liu","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.thromres.2024.109041_bb0125","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1016\/j.ijbiomac.2020.08.150","article-title":"Purification, structural characterization and anticoagulant activities of four sulfated polysaccharides from sea cucumber Holothuria fuscopunctata","volume":"164","author":"Gao","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"36","key":"10.1016\/j.thromres.2024.109041_bb0130","doi-asserted-by":"crossref","first-page":"14089","DOI":"10.1074\/jbc.RA118.003809","article-title":"Oligosaccharides from depolymerized fucosylated glycosaminoglycan: structures and minimum size for intrinsic factor Xase complex inhibition","volume":"293","author":"Yin","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"38","key":"10.1016\/j.thromres.2024.109041_bb0135","doi-asserted-by":"crossref","first-page":"11316","DOI":"10.1021\/bi0342923","article-title":"Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa","volume":"42","author":"Sheehan","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.thromres.2024.109041_bb0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.carbpol.2015.04.002","article-title":"\u03b2-Eliminative depolymerization of the fucosylated chondroitin sulfate and anticoagulant activities of resulting fragments","volume":"127","author":"Gao","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.thromres.2024.109041_bb0145","unstructured":"ICH. ICH Guideline M10 on Bioanalytical Method Validation and Study Sample Analysis. 2022. https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf (accessed 22 February 2024)."},{"issue":"9_suppl","key":"10.1016\/j.thromres.2024.109041_bb0150","doi-asserted-by":"crossref","first-page":"150S","DOI":"10.1177\/1076029618798956","article-title":"Comparative pharmacokinetic profile of 3 batches of ovine low-molecular-weight heparin and 1 batch of branded enoxaparin","volume":"24","author":"Jeske","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.thromres.2024.109041_bb0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/md16040132","article-title":"Pharmacokinetic and tissue distribution of fucoidan from Fucus vesiculosus after oral administration to rats","volume":"16","author":"Pozharitskaya","year":"2018","journal-title":"Mar. Drugs"},{"issue":"3","key":"10.1016\/j.thromres.2024.109041_bb0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0049-3848(98)00171-6","article-title":"Oral absorption and clearance of partially depolymerized fucosyl chondroitin sulfate from sea cucumber","volume":"93","author":"Imanari","year":"1999","journal-title":"Thromb. Res."},{"issue":"27","key":"10.1016\/j.thromres.2024.109041_bb0165","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1073\/pnas.1504229112","article-title":"Discovery of an intrinsic tenase complex inhibitor: pure nonasaccharide from fucosylated glycosaminoglycan","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2024.109041_bb0170","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejmech.2018.02.047","article-title":"Precise structures of fucosylated glycosaminoglycan and its oligosaccharides as novel intrinsic factor Xase inhibitors","volume":"148","author":"Shang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"39","key":"10.1016\/j.thromres.2024.109041_bb0175","doi-asserted-by":"crossref","first-page":"12880","DOI":"10.1002\/anie.201807546","article-title":"Synthesis of fucosylated chondroitin sulfate nonasaccharide as a novel anticoagulant targeting intrinsic factor Xase complex","volume":"57","author":"Zhang","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.thromres.2024.109041_bb0180","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/jacsau.2c00569","article-title":"Glycosaminoglycans: what remains to be deciphered?","volume":"3","author":"Perez","year":"2023","journal-title":"JACS Au"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:01:48Z","timestamp":1720044108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":36,"alternative-id":["S0049384824001737"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109041","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure and pharmacokinetics\/pharmacodynamics of the anticoagulant tetradecasaccharide oHG-14 as an intrinsic tenase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109041"}}